Pablo Corral: How Low Should LDL-C Go After Ischemic Stroke?
Pablo Corral, Pharmacology Professor at FASTA University, Past President of Argentine Lipid Society, shared on LinkedIn about a recent article by Victorien Monguillon et al, published in Circulation:
”How Low Should LDL-C Go After Ischemic Stroke?
Not theoretical anymore. Not opinion.
Data:
- Lower LDL-C, fewer cardiovascular events
- Lower LDL-C, fewer recurrent strokes
- Benefit continues below 40 mg/dL
And importantly:
- No excess hemorrhagic stroke
- No safety signal
- Consistent risk reduction
The real question is no longer how low is too low. It is:
Why are we still leaving stroke patients exposed to avoidable LDL risk?
After ischemic stroke: Aggressive LDL lowering is prevention
Title: Efficacy and Safety of Very Low Achieved LDL Cholesterol in Patients With Previous Ischemic Stroke
Authors: Victorien Monguillon, Peter Kelly, Michelle O’Donoghue, Jeong-Gun Park, Erin Bohula, Jeffrey Saver, Dan Atar, Anthony Keech, Peter Sever, Huei Wang, Gabriel Paiva da Silva Lima, Marc Sabatine, Robert Giugliano
Read the Full Article on Circulation
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 20, 2026, 05:46Jan T. Kielstein: DNP Poisoning and Hemoadsorption The Limits of Rescue Therapy
-
Oct 20, 2026, 05:33Giulia Di Paolo: Connecting Plasma Donation to the Patients Who Depend on It
-
Oct 20, 2026, 05:20James Knowles: Exploring Plasma Manufacturing and Strengthening Industry Collaboration
-
Oct 20, 2026, 05:11Giuseppe Lippi։ Understanding Liver Test Abnormalities After AAV Gene Therapy
-
Oct 20, 2026, 05:02Sanam Loghavi: Test Your Hematology Knowledge at ASH 2026!
-
Oct 20, 2026, 04:13Ifeanyichukwu Ifechidere: DOACs Are Not the Answer to Every Anticoagulation Question
-
Oct 20, 2026, 04:04Sadia Kamal: Honored to Receive the Outstanding Abstract Award at the 20th Midwest Platelet Conference
-
Oct 20, 2026, 04:03Yu-Hsuan Chen: One Antibody, Two Diseases from FcRn Biology to Clinical Translation
-
Oct 20, 2026, 03:49Domenico Simone Castiello: Rethinking Prolonged DAPT in Multivessel PCI – Insights from the DAPT-MVD Trial